{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:24:24Z","timestamp":1792628664573,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>T cell\u2013mediated rejection (TCMR) is the most frequent type of acute rejection and is associated with kidney allograft failure. Almost 40% of TCMR episodes are nonresponsive to therapy, and molecular mechanisms for the nonresponsiveness are unknown. Our single-center study identified that urinary cell FOXP3 mRNA abundance predicts TCMR reversibility and allograft survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We developed PCR assays and measured absolute copy numbers of transcripts for FOXP3, CD25, CD3E, perforin, and 18S rRNA in 3559 urines from 480 kidney allograft recipients prospectively enrolled in the multicenter Clinical Trials in Organ Transplantation-04. In this replication study, we investigated the association between mRNA profile and TCMR diagnosis, TCMR reversibility, and allograft survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      18S rRNA normalized levels of mRNA for FOXP3 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01, Kruskal-Wallis test), CD25 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01), CD3E (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001), and perforin (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001) were diagnostic of TCMR, but only FOXP3 mRNA level predicted TCMR reversibility (ROC AUC = 0.764; 95% confidence interval, 0.611-0.917;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008). Multivariable logistic regression analyses showed that urinary cell FOXP3 mRNA level predicted reversal, independent of clinical variables. A composite model of clinical variables and FOXP3 mRNA (AUC = 0.889; 95% CI, 0.781-0.997;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) outperformed FOXP3 mRNA or clinical variables in predicting TCMR reversibility (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01, likelihood ratio test). Multivariable Cox proportional hazards regression analyses showed that FOXP3 mRNA level predicts kidney allograft survival (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.047) but not after controlling for TCMR reversal (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.477).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Urinary cell level of FOXP3 mRNA is diagnostic of TCMR, predicts TCMR reversibility, and is prognostic of kidney allograft survival via a mechanism involving TCMR reversal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000003478","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T07:10:50Z","timestamp":1602141050000},"page":"1825-1839","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["FOXP3 mRNA Profile Prognostic of Acute T Cell\u2013mediated Rejection and Human Kidney Allograft Survival"],"prefix":"10.1097","volume":"105","author":[{"given":"Danny","family":"Luan","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshana M.","family":"Dadhania","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."},{"name":"Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchuang","family":"Ding","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thangamani","family":"Muthukumar","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."},{"name":"Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lubetzky","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."},{"name":"Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."},{"name":"Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis","family":"August","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."},{"name":"Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco B.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."},{"name":"Department of Psychiatry and Behavioral Health, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikkam","family":"Suthanthiran","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."},{"name":"Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/TP.0b013e3181661695","article-title":"Influence of time of rejection on long-term graft survival in renal transplantation.","volume":"85","author":"Opelz","year":"2008","journal-title":"Transplantation"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/ajt.12370","article-title":"Kidney allograft survival after acute rejection, the value of follow-up biopsies.","volume":"13","author":"El Ters","year":"2013","journal-title":"Am J Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/ajt.12426","article-title":"Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.","volume":"13","author":"Hricik","year":"2013","journal-title":"Am J Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1215555","article-title":"Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.","volume":"369","author":"Suthanthiran","year":"2013","journal-title":"N Engl J Med"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/ajt.15299","article-title":"Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.","volume":"19","author":"Bouatou","year":"2019","journal-title":"Am J Transplant"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1046\/j.1523-1755.2001.00030.x","article-title":"International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project.","volume":"60","author":"Furness","year":"2001","journal-title":"Kidney Int"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.TP.0000082542.99416.11","article-title":"Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates.","volume":"76","author":"Furness","year":"2003","journal-title":"Transplantation"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa051907","article-title":"Messenger RNA for FOXP3 in the urine of renal-allograft recipients.","volume":"353","author":"Muthukumar","year":"2005","journal-title":"N Engl J Med"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T Cells and Human Disease.","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","article-title":"Regulatory T cells: The many faces of Foxp3.","volume":"39","author":"Georgiev","year":"2019","journal-title":"J Clin Immunol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.4049\/jimmunol.172.10.6003","article-title":"Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.","volume":"172","author":"Cobbold","year":"2004","journal-title":"J Immunol"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/eji.200526077","article-title":"Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.","volume":"35","author":"Albert","year":"2005","journal-title":"Eur J Immunol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI122083","article-title":"Bronchus-associated lymphoid tissue-resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection.","volume":"129","author":"Li","year":"2019","journal-title":"J Clin Invest"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity.","volume":"10","author":"Romano","year":"2019","journal-title":"Front Immunol"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy.","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/533452a","article-title":"1,500 scientists lift the lid on reproducibility.","volume":"533","author":"Baker","year":"2016","journal-title":"Nature"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1250475","article-title":"Reproducibility.","volume":"343","author":"McNutt","year":"2014","journal-title":"Science"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/0962280206070637","article-title":"A solution for the most basic optimization problem associated with an ROC curve.","volume":"15","author":"Le","year":"2006","journal-title":"Stat Methods Med Res"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves.","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria\u2014An addition to the Banff 97 classification of renal allograft rejection.","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"R22-20250604","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ajt.15274","article-title":"OPTN\/SRTR 2017 annual data report: kidney.","volume":"19","author":"Hart","year":"2019","journal-title":"Am J Transplant"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"e131552","DOI":"10.1172\/jci.insight.131552","article-title":"Urinary cell transcriptomics and acute rejection in human kidney allografts.","volume":"5","author":"Verma","year":"2020","journal-title":"JCI Insight"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/TP.0000000000002911","article-title":"Long-term kinetics of intragraft gene signatures in renal allograft tolerance induced by transient mixed chimerism.","volume":"103","author":"Matsunami","year":"2019","journal-title":"Transplantation"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/TP.0b013e3181a24a4b","article-title":"Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome.","volume":"87","author":"Yapici","year":"2009","journal-title":"Transplantation"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/0886022X.2013.766568","article-title":"Analysis of FOXP3 gene and protein expressions in renal allograft biopsies and their association with graft outcomes.","volume":"35","author":"Dummer","year":"2013","journal-title":"Ren Fail"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/ajt.15197","article-title":"The clinical and pathological significance of borderline T cell-mediated rejection.","volume":"19","author":"Nankivell","year":"2019","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:15:01Z","timestamp":1749050101000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003478","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.28.20083493","asserted-by":"object"}]},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,20]]}}}